Harmon Seth
SEC insider (Form 3/4/5 filer). CIK 0001993300. Chief Financial Officer at Viridian Therapeutics, Inc.\DE (VRDN). 7 reported Form 4/5 transactions since Sep 2024; latest on Mar 3, 2026. Located in WALTHAM, MA.
Companies Harmon Seth has filed insider reports for
- Viridian Therapeutics, Inc.\DE (VRDN): Officer, Chief Financial Officer
Harmon Seth
CIK: 0001993300
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Viridian Therapeutics, Inc.\DE
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Mar 3, 2026VRDN
Viridian Therapeutics, Inc.\DE
Tax PaymentDirect2K shares at avg. $30.19$61K - Mar 3, 2026VRDN
Viridian Therapeutics, Inc.\DE
ExerciseDirect6.3K shares- - Mar 3, 2026VRDN
Viridian Therapeutics, Inc.\DE
Tax PaymentDirect2.1K shares at avg. $29.32$61K - Mar 2, 2026VRDN
Viridian Therapeutics, Inc.\DE
AwardDirectStock Option (Right to Buy)
102.9K shares- - Mar 2, 2026VRDN
Viridian Therapeutics, Inc.\DE
AwardDirectRestricted Stock Units
20.6K shares- - Mar 3, 2025VRDN
Viridian Therapeutics, Inc.\DE
AwardDirectStock Option (Right to Buy)
150.4K shares- - Mar 3, 2025VRDN
Viridian Therapeutics, Inc.\DE
AwardDirectRestricted Stock Units
25.1K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 3, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Tax Payment | 2,031 | $30.19 | $61,316 | Direct |
| Mar 3, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Exercise | 6,267 | - | $0 | Direct |
| Mar 3, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Tax Payment | 2,091 | $29.32 | $61,308 | Direct |
| Mar 2, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Award Stock Option (Right to Buy) | 102,850 | - | - | Direct |
| Mar 2, 2026 | VRDN Viridian Therapeutics, Inc.\DE | Award Restricted Stock Units | 20,550 | - | - | Direct |
| Mar 3, 2025 | VRDN Viridian Therapeutics, Inc.\DE | Award Stock Option (Right to Buy) | 150,407 | - | - | Direct |
| Mar 3, 2025 | VRDN Viridian Therapeutics, Inc.\DE | Award Restricted Stock Units | 25,068 | - | - | Direct |
1-7 of 7 transactions